May 5, 2023, 16:32 by

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

May 5, 2023, 16:32 by

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

May 5, 2023, 16:32 by

Discover how Electronic Data Capture (EDC) revolutionizes clinical trials by streamlining data collection, improving accuracy, and ensuring compliance. Explore the advantages of EDC and its impact on efficient clinical research.

May 5, 2023, 16:32 by

Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science products, in a new global rental agreement.

May 3, 2023, 01:00 by User Not Found

Clinical Research News | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.

May 2, 2023, 01:00 by User Not Found

Clinical Research News | When Seqster was first founded in 2016, co-founder Ardy Arianpour had a lot of experience in next-gen sequencing and a vision for how consumers could control their health information. Seqster is more than a company, Arianpour insists to host, Deborah Borfitz, in the latest Scope of Things podcast. “This is a movement.”

Apr 27, 2023, 01:00 by User Not Found

Clinical Research News | Greenphire launches a new patient-facing digital platform, Medidata’s AI Intelligent Trials platform will support Launch Therapeutics, gold-based compounds target “superbugs”, The University of Chicago Medicine Comprehensive Cancer Center has been named the newest member institution of the National Comprehensive Cancer Network Agency, and more.

Apr 26, 2023, 01:00 by User Not Found

Clinical Research News | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.

Apr 25, 2023, 11:42 by

Apr 25, 2023, 11:42 by

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts. The site has specialized in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease for over 25 years. This acquisition deepens Headland Research's existing expertise in neurology.

Apr 25, 2023, 11:42 by

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Apr 25, 2023, 11:42 by

Indica Labs has announced a global strategic partnership with Xyall to bridge the gap between histology and molecular pathology.

Apr 25, 2023, 11:42 by

Apr 25, 2023, 11:42 by

The financing will advance ClinOne’s technology, accelerate growth, and drive expansion to serve clinical sites, participants, and families in clinical trials.

Apr 25, 2023, 11:42 by

Apr 25, 2023, 11:42 by

Apr 25, 2023, 11:40 by

In recent years, eProtocol automation has emerged as a powerful tool for streamlining the protocol creation process, reducing errors, and improving efficiency.

Apr 25, 2023, 11:40 by

Apr 25, 2023, 11:40 by

Apr 25, 2023, 11:40 by